Chaim Lebovits - May 28, 2024 Form 4/A Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & CEO
Signature
/s/ Chaim Lebovits
Stock symbol
BCLI
Transactions as of
May 28, 2024
Transactions value $
$7,775
Form type
4/A
Date filed
7/31/2024, 04:09 PM
Date Of Original Report
Jun 3, 2024
Previous filing
May 23, 2024
Next filing
Oct 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Purchase $7.77K +15K +1.3% $0.52 1.16M May 28, 2024 Direct F1, F2
holding BCLI Common Stock 2M May 28, 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 3, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
F2 The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.